TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+1.62%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.38B
AUM Growth
+$2.38B
(+1.4%)
Cap. Flow
+$234K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
40.59%
Holding
153
New
10
Increased
26
Reduced
19
Closed
10
Top Buys
| 1 |
Abbott
ABT
|
$37.5M |
| 2 |
Cencora
COR
|
$29.9M |
| 3 |
CVS Health
CVS
|
$21.4M |
| 4 |
Neurocrine Biosciences
NBIX
|
$20.7M |
| 5 |
Gilead Sciences
GILD
|
$15.1M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$34.4M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$24.8M |
| 3 |
Novo Nordisk
NVO
|
$16M |
| 4 |
Ventas
VTR
|
$15.8M |
| 5 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
$14.7M |
Sector Composition
| 1 | Healthcare | 88.83% |
| 2 | Real Estate | 2.74% |
